roundtable discussion: cell and gene therapies — keep the work in-house, or use a third party?
Published 3 years ago • 53 plays • Length 43:04Download video MP4
Download video MP3
Similar videos
-
59:41
the role of new technologies in enabling cell and gene therapies
-
18:15
the critical role of cell culture media analysis in cell and gene therapies development
-
57:04
in-house manufacturing capabilities gives cell and gene therapy developers a competitive advantage
-
33:07
accelerate cell and gene therapy development and increase manufacturing capacity....
-
16:25
fda’s efforts to advance the development and approval of cellular and gene therapies
-
52:32
panel: when does investing in cell and gene therapy make business sense?
-
13:20
2021 reuters cell & gene therapy
-
1:04:36
synbyss with dr christina smolke at antheia & dr simone giaveri at max planck inst for terr. microb.
-
57:23
feeding the demand for cell and gene therapy production
-
37:14
2022 wmif | gene and cell therapy | the world speaks
-
59:45
webinar: manufacturing challenges facing cell and gene therapy
-
27:43
overview of standards setting for cell/gene therapies-- case studies
-
59:51
panel: next generation cell and gene therapy in oncology
-
43:46
ft pharma 2021 - the next generation of cell and gene therapies session
-
23:42
a view on manufacturing cell and gene therapies
-
1:12:47
understanding gmp reagents and their role in cell therapy
-
25:09
bone marrow stem cells/gene therapy
-
28:45
meeting on the mesa keynote speaker: taking cell and gene therapy to the next level